Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Liquid Ready-to-use Tumour Marker Control available now from Randox

Published: Thursday, November 22, 2012
Last Updated: Thursday, November 22, 2012
Bookmark and Share
The new Randox Acusera multi-analyte Liquid Tumour Marker Control covers a total of 15 commonly tested and esoteric cancer antigens and tumour markers.

The inclusion of assayed, instrument specific target values enables laboratories to effectively monitor both accuracy and precision.

The Liquid Tumour Marker Control includes AFP (Alpha-fetoprotein), Beta-2- Microglobulin, CA15-3,3xVials01---New-Randox-TM-c.gif CA19-9, CA27-29, CA72-4, CA125, CEA (Carcinoembryonic Antigen), Cyfra 21-1, Ferritin, hCG (Human Chorionic Gonadotropin), NSE (Neuron-specific Enolase), PSA Free (Prostate Specific Antigen Free), PSA Total (Prostate Specific Antigen Total) and Thyroglobulin.

The liquid ready-to-use format is highly convenient for laboratory staff to use requiring no preparation. Furthermore the material can be easily shipped and stored at +2-8oC.  Liquid stable controls not only eliminate the need for reconstitution but reduce the amount of human handling necessary. The user friendly 6 x 3ml pack size and open vial stability of 30 days at +2-8oC for all analytes listed significantly helps to minimise waste and keep running costs low.

Like all Randox immunoassay controls the serum is 100% human in origin providing a matrix similar to the patient sample but also reducing antibody cross reactivity and the possibility of control values shifting when reagent batch is changed. Three distinct levels of control are available with all analytes including PSA present at desirable levels.  Clinically relevant PSA levels ensure the ratio of free to bound PSA is typical of that found in cancer patients.

As a true third party control laboratories can use the Acusera liquid tumour marker control to independently assess analytical performance.  Fully assayed, instrument specific target values and ranges are provided for many common clinical chemistry and immunoassay systems.

For optimum performance and advanced analytical capabilities use in combination with Acusera 24.7 Live Online, an inter-laboratory data management programme designed to monitor analytical performance, interpret QC results and improve the effectiveness of quality control. With Acusera 24.7 users benefit from online access anytime, peer group data generated from thousands of laboratories every 24 hours, fully interactive charts and reports and automatic import of QC data direct from your LIMs or instrument via Acusera 24.7 Connect.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Natural Protein Points to New Inflammation Treatment
Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.
Natural Protein Points to New Inflammation Treatment
Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.
Enzyme Links Age-Related Inflammation, Cancer
Researchers have shown that an enzyme key to regulating gene expression -- and also an oncogene when mutated -- is critical for the expression of numerous inflammatory compounds that have been implicated in age-related increases in cancer and tissue degeneration.
New Biomarker to Assess Stem Cells Developed
A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs). The team's discovery offers a new way to fast-track screening methods used in stem cell research.
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
Crouching Protein, Hidden Enzyme
A new study led by scientists at The Scripps Research Institute (TSRI) and the University of California (UC), Berkeley shows how a crucial molecular enzyme starts in a tucked-in somersault position and flips out when it encounters the right target.
HIV Protein Manipulates Hundreds of Human Genes
Findings search for new or improved treatments for patients with AIDS.
First 3-D Vision of Cancer Target
This basic research set the grounds for structure-based drug design approaches that could be beneficial for cancer treatments' - Dr. Cyril Dominguez, University of Leicester.
New Light Shed on Genetic Regulation
A team of scientists has uncovered greater intricacy in protein signaling than was previously understood, shedding new light on the nature of genetic production.
Hacking the Programs of Cancer Stem Cells
All tumor cells are the offspring of a single, aberrant cell, but they are not all alike.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!